TABLE 2.
Start | Stop | Peptide sequencea | Phosphorylation site | Ascorec |
---|---|---|---|---|
316 | 328 | SsGsVAsLPQSDR | Ser-317b | 14.04 |
Ser-319b | 26.31 | |||
Ser-322b | 34.3 | |||
316 | 344 | SSGSVASLPQSDRSSSSsQESLNRPFSSK | Ser-333 | 18.53 |
329 | 344 | SSSSsQESLNRPFSSK | Ser-333 | 10.11 |
374 | 387 | sRsDIDVNAAAGAK | Ser-374 | 9.38 |
Ser-376 | 29.27 | |||
467 | 488 | sGsPGRVLtTtALSTVSSGAQR | Ser-467b | 0 |
Ser-469b | 5.42 | |||
Thr-475b | 0.21 | |||
Thr-477b | 0.32 | |||
567 | 575 | LSSsVSAmR | Ser-570b | 0 |
935 | 957 | GVTEAIQNFSFRsQEDmSEPLKR | Ser-947b | 5.3 |
994 | 1007 | ASLLHSVPLHSsPR | Ser-1005b | 27.96 |
1008 | 1024 | SRDYNPYNYSDSIsPFNK | Ser-1021 | 25.7 |
1174 | 1192 | VLCPIIQtADYPINLAAIK | Thr-1181b | 28.73 |
a Lower case s/t represents phospho-site. Lower case m represents methionine oxidation site.
b Novel, previously unreported phosphorylation site.
c Ascore ≥20 signifies 99% certainty, 15–19 equals >90%, 3–15 is near 80% yet nonsufficient, and <3 lacks adequate information to make an assignment.